Skip to content
  • What’s
    Your Focus
    • Develop Anti-Aging Interventions
    • Validate and Expand Health Claims
    • Target Age-Related Diseases
    • Study the Biology of Aging
    • Ensure the Safety of Your Products
    • I want to start working with NAMs
  • Products &
    Assays
    • Organism-on-Chip technology
    • SydLab™ One Platform
    • Nagi™ B-Age
    • Nagi™ B-Age for Gut Health
    • Consumables & Reagents
    • SydLab™ Analyzer Software Modules
  • Contract
    Research Services
    • Aging and Longevity Studies
    • Neurodegenerative Studies
    • Toxicity Studies
    • Compound Efficacy Studies
    • Microbiome Studies
    • Custom Studies
  • Applications
    • Fundamental Research
      • Aging and age-related Diseases
      • Neurodegenerative Diseases
    • Candidate Discovery
      • Aging and age-related Diseases
      • Neurodegenerative Diseases
    • Safety Toxicology
      • Developmental and Reproductive Toxicity
  • Resources
    • Resource Center
    • Nagi Blog
  • About Nagi
    • Our story
    • News
    • Events
    • Careers
  • Contact us
  • LinkedIn
  • X
  • Nagi Bioscience successfully passed Venture Kick Stage 2

    Nagi Bioscience successfully passed Venture Kick Stage 2

    Nagi Bioscience passed stage 2 of Venture Kick! Let’s continue on our way: stage 3, here we come!

    June 29, 2018
  • Nagi Bioscience technology catches the attention in the Cosmic Field

    Nagi Bioscience technology catches the attention in the Cosmic Field

    According to the french web media Wydden, Nagi Bioscience is one of the 10 startups to follow in the BeautyTech industry!  You can read the article published online by Wydden here. Good reading!

    June 29, 2018
  • We are in the news!

    We are in the news!

    Nagi Bioscience is featured today in the online version of French Economic TV channel BFMTV. This article (in French) introduces the technology developed by our startup and its application for avoiding testing on animals for cosmetic, chemical industries and pharmas. You can read the article online here. Good reading!

    June 9, 2018
  • We are in the news!

    We are in the news!

    Nagi Bioscience is featured today in the Economic Swiss newspaper Bilan. This article (in French) presents our startup and its device that avoids testing on animals for cosmetic, chemical industries and pharmas. You can read the article online here. Good reading!

    May 29, 2018
  • Nagi Bioscience is part of the 2018 MassChallenge acceleration program

    Nagi Bioscience is part of the 2018 MassChallenge acceleration program

    We are glad to announce that Nagi is among the 66 high-impact startups that will join the final stage of the MassChallenge acceleration program. Our startup will benefit from world-class mentorship, programming, and resources during for improving our business case. The accelerator program will start in June and culminate on October 30th at the MassChallenge Switzerland Awards Ceremony.…

    May 24, 2018
  • We are in the news!

    We are in the news!

    Matteo and Laurent appeared respectively in two radio show broadcasted on the Swiss Radio RTS. They discuss the today’s problematic of animal testing and how the technology developed by Nagi Bioscience can bring an innovative solution to solve this issue. You can listen the live interview of Matteo and Laurent here and here (in French).

    May 20, 2018
  • Nagi Bioscience won the PERL Biotech Award 2018

    Nagi Bioscience won the PERL Biotech Award 2018

    Our CSO Laurent Mouchiroud received the prestigious PERL (Prix Entreprendre Région Lausanne) Biotech Award 2018 during a ceremony held at the Theatre de Beaulieu in Lausanne. Each year, the PERL jury, made up of academic, economic and media representatives, is responsible for selecting and nominate the laureates. These laureates will benefit, before and after the prize-giving ceremony, from…

    May 2, 2018
  • Our technology is featured on the front page of the EPFL website

    Our technology is featured on the front page of the EPFL website

    An interview with Matteo Cornaglia, our CEO, was published on te front page of the EPFL website, providing some insight about the how and why of the technology developed by Nagi Bioscience. You can see the video entitled “Tech-Transfer:worms in high-tech housing replace laboratory mice” here.

    May 1, 2018
  • Matteo was selected for Venture Leaders Life Sciences 2018

    Matteo was selected for Venture Leaders Life Sciences 2018

    Every year, 10 Swiss-based entrepreneurs with international high potential are selected by venturelab for the Swiss National Startup Team. The members of this team, the venture leaders, win a week entrepreneurial and business development training based in the Boston, US. In the context of the program, he is going to pitch at the Startup Champions Seed Night on…

    April 5, 2018
  • Nagi Bioscience passed Venture Kick stage 1

    Nagi Bioscience passed Venture Kick stage 1

    Great news: Nagi Bioscience passed stage 1 of Venture Kick! On the way for stage 2 now! Venture Kick was launched in 2007 with the vision to double the number of spin-offs at Swiss universities, to accelerate the time-to-market and to raise the attractiveness of these young companies to professional investors and industry partners. Selected members from a jury pool with…

    March 29, 2018
←Previous Page
1 … 3 4 5 6 7
Next Page→
    • LinkedIn
    • X

Contact

Nagi Bioscience SA
EPFL Innovation Park (M)
Rue des Jordils 1A
1025 Saint-Sulpice, Switzerland
Email: info@nagibio.ch

Links

  • Contract Laboratories Solutions
  • Applications
  • Industries
  • Resources
  • About Nagi
  • Contact Us

Legal

  • Change Cookie Settings
  • Terms and Conditions
  • Privacy Policy

© 2025 Nagi Bioscience • All rights reserved